2020 - Year of COVID-19

J Thromb Haemost. 2020 Sep;18(9):2081. doi: 10.1111/jth.15041.

Authors

David Lillicrap¹, James H Morrissey²

Affiliations

¹ Department of Pathology and Molecular Medicine, Queen's University, Kingston, ON, Canada.
² Departments of Biological Chemistry and Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.

No abstract available

Publication types

Editorial

MeSH terms

Anticoagulants / therapeutic use*
Betacoronavirus / pathogenicity*
Blood Coagulation / drug effects*
Blood Coagulation Disorders / blood
Blood Coagulation Disorders / drug therapy*
Blood Coagulation Disorders / mortality
Blood Coagulation Disorders / virology
COVID-19
Coronavirus Infections / blood
Coronavirus Infections / drug therapy*
Coronavirus Infections / mortality
Coronavirus Infections / virology
Host-Pathogen Interactions
Humans
Pandemics
Periodicals as Topic*
Pneumonia, Viral / blood
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / mortality
Pneumonia, Viral / virology
SARS-CoV-2
Treatment Outcome

Substances

Anticoagulants